HIV post-exposure prophylaxis

Revisión del 23:11 29 oct 2010 de Robot (discusión | contribs.) (Created page with "1) Td 2) Hepatitis B PEP for non-vaccinated -Hepatitis B immunoglobulin and/or vaccine 3) Source labs -Rapid HIV, hep pannel, RPR? 4) Exposed labs -Rapid HIV...")
(difs.) ← Revisión anterior | Revisión actual (difs.) | Revisión siguiente → (difs.)

1) Td

2) Hepatitis B PEP for non-vaccinated

    -Hepatitis B immunoglobulin and/or vaccine

3) Source labs

    -Rapid HIV, hep pannel, RPR?

4) Exposed labs

    -Rapid HIV, hep pannel, RPR?

5) Consider HIV PEP

    -CBC, C7, LFTs, Icon if considering HIV PEP
  • Currently no PEP for Hep C


HIV PEP

~79% transmission reduction

Initiate ASAP (goal = 1-2 hours)

>36 hours: normally deferred, unless particularly high risk

Common side-effects = constitutional, gastrointestinal


CDC website lists specific regimens

1) Basic

-Exposures for which there is a recognized transmission risk

-4 week, 2 drug regimen (normally zidovudine and lamivudine)

2) Expanded

-High risk exposures

-Basic regimen + protease inhibitor (e.g. indinavir or nelfinavir)


HIGH RISK

Source

-Symptomatic HIV/AIDS

-Acute seroconversion

-High viral load

Exposure

-Deep injuries

-Visible blood on device

-Injuries sustained placing a catheter in a vein/artery


8/07 DONALDSON